<i>TH-MYCN</i> tumors, but not tumor-derived cell lines, are adrenergic lineage, GD2+, and responsive to anti-GD2 antibody therapy.

Oncoimmunology · 2022 · PMC9132414 · PMID 35646475

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Conversely, a trend toward a larger proportion of neuroblasts expressed Rae-1γ in mice treated with 14G2a relative to the isotype control antibody, although this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.